ribution patterns or reimbursement
rates for health-care products and/or services; the results, consequences,
effects or timing of any inquiry or investigation by any regulatory
authority or any legal or administrative proceedings; future actions of
regulatory bodies or government authorities relating to Cardinal Health's
manufacturing or sale of products and other costs or claims that could
arise from its manufacturing, compounding or repackaging operations or from
its other services; the costs, difficulties and uncertainties related to
the integration of acquired businesses; and conditions in the
pharmaceutical market and general economic and market conditions. This news
release reflects management's views as of May 1, 2008. Except to the extent
required by applicable law, Cardinal Health undertakes no obligation to
update or revise any forward-looking statement.
CARDINAL HEALTH, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)
(in millions, except per Common Third Quarter
Share amounts) 2008 2007 % Change
Revenue $22,909.6 $21,867.1 5%
Cost of products sold 21,441.8 20,479.6 5%
Gross margin 1,467.8 1,387.5 6%
Selling, general and administrative
expenses 854.5 781.7 9%
Impairment charges and other 1.2 3.6 N.M.
Restructuring charges 8.5 6.6 N.M.
Acquisition integration charges 4.4 2.9 N.M.
Litigation and other 22.7 602.5 N.M.
Operating earnings / (loss) 576.5 (9.8) N.M.
Interest expense and other Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Related medicine news :1
. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook2
. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years3
. Cardinal Health To Announce First-Quarter Results on November 54
. Cardinal Health Announces Sector Management Change5
. Cardinal Health Reports First Quarter Results6
. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved7
. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility8
. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign9
. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility10
. Cardinal Health to Announce Second-Quarter Results on January 2911
. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector